Objective: To update information on misoprostol obstetrical use in order to determine availability mapping in Latin America and the Caribbean countries. Design: Survey type study. setting: Latin America and the Caribbean countries. Participants: Public and prívate sources. Methodology: A survey semiestructured format was elaborated and sent to key Latin America and the Caribbean informers. They consulted different public and private sources in each country. Answers were ncorporated in a database to obtain frequencies of each variable studied. main outcome measures: Misoprostol trademarks, content and availability. Results: Misoprostol is obtained in different trademarks in Latin America and the Caribbean, usually in 200 μg oral tablets presentations and only one is presented as 25, 50, 100 y 200 μg vaginal tablets. Few presentations associate misoprostol to an antiinflammatory. There ...

Objective: To update information on misoprostol obstetrical use in order to determine availability mapping in Latin America and the Caribbean countries. Design: Survey type study. setting: Latin America and the Caribbean countries. Participants: Public and prívate sources. Methodology: A survey semiestructured format was elaborated and sent to key Latin America and the Caribbean informers. They consulted different public and private sources in each country. Answers were ncorporated in a database to obtain frequencies of each variable studied. main outcome measures: Misoprostol trademarks, content and availability. Results: Misoprostol is obtained in different trademarks in Latin America and the Caribbean, usually in 200 μg oral tablets presentations and only one is presented as 25, 50, 100 y 200 μg vaginal tablets. Few presentations associate misoprostol to an antiinflammatory. There ...